by angelliu | Oct 14, 2026 | News
Source: Fierce Pharma Expanding its presence in dermatology, Cetaphil maker Galderma has agreed to acquire professional skincare shop Zo Skin Health for $1.5 billion. The all-cash transaction is designed to bolster Galderma’s footprint in the medical-grade skincare...
by angelliu | Jun 22, 2026 | News
Source: Fierce Biotech AbbVie has struck a deal to buy Apogee Therapeutics for $10.9 billion. The deal will give AbbVie control of a late-phase eczema drug candidate that could pose a threat to Eli Lilly, Regeneron and Sanofi. Apogee’s lead candidate is zumilokibart,...
by angelliu | Mar 5, 2025 | News
Source: Fierce Biotech Jazz Pharmaceuticals has drummed up a deal in double time, agreeing to buy Chimerix for $935 million just days after its CEO voiced an interest in diversifying the pipeline. Buying Chimerix will give Jazz control of the brain cancer drug...
by angelliu | Dec 16, 2024 | News
Source: FiercePharma The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD). Both products now will be available to a significantly larger patient population as roughly 26 million in the U.S. have...
